This is not the most recent version of the article. View current version (15 NOV 2013)

Intervention Review

Haloperidol versus placebo for schizophrenia

  1. CB Joy,
  2. CE Adams,
  3. SM Lawrie

Editorial Group: Cochrane Schizophrenia Group

Published Online: 23 APR 2001

DOI: 10.1002/14651858.CD003082

How to Cite

Joy CB, Adams CE, Lawrie SM. Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD003082. DOI: 10.1002/14651858.CD003082.

Author Information

*Mrs Claire Joy, Research Assistant, Department of Psychiatry & Behavioural Sciences, University of Leeds, 15-19 Hyde Terrace, Leeds, LS2 9LT, UK.

Publication History

  1. Published Online: 23 APR 2001


This is not the most recent version of the article. View current version (15 NOV 2013)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.